Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Traws Pharma Inc (TRAW)

Traws Pharma Inc (TRAW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Traws Pharma Inc 12 PENNS TRAIL NEWTOWN PA 18940 USA

www.trawspharma.com Employees: 7 P: 267-759-3680 F: 267-759-3681

Sector:

Medical

Description:

Traws Pharma Inc. is involved in developing antivirals for influenza, COVID and other respiratory infections and narazaciclib. Traws Pharma Inc., formerly known as Onconova Therapeutics Inc., is based in NEWTOWN, Pa.

Key Statistics

Overview:

Market Capitalization, $K 12,865
Enterprise Value, $K -8,475
Shares Outstanding, K 7,991
Float, K 6,872
% Float 86.00%
Short Interest, K 506
Short Float 6.33%
Days to Cover 1.29
Short Volume Ratio 0.62
% of Insider Shareholders 14.00%
% of Institutional Shareholders 7.95%

Financials:

Annual Sales, $ 230 K
Annual Net Income, $ -166,520 K
Last Quarter Sales, $ 2,730 K
Last Quarter Net Income, $ -920 K
EBIT, $ -20,270 K
EBITDA, $ -20,260 K

Growth:

1-Year Return -65.67%
3-Year Return -92.15%
5-Year Return -99.66%
5-Year Revenue Growth -89.45%
5-Year Earnings Growth 93.70%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.34 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm 88.83
EPS Growth vs. Prev Qtr -209.09%
EPS Growth vs. Prev Year 96.14%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 09/23/24

TRAW Ratios

Ratio
Price/Earnings ttm 0.02
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,883.04%
Return-on-Assets % 512.82%
Profit Margin % -72,400.00%
Debt/Equity 0.00
Price/Sales 3.83
Price/Cash Flow N/A
Price/Book 2.46
Book Value/Share 1.49
Interest Coverage -12.55
60-Month Beta 1.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar